Status:
COMPLETED
COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
COVID-19
SARS-CoV2 Infection
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to investigate the clinical performance characteristics of the novel point-of-care, semi-quantitative test for SARS-CoV-2 in the Emergency Department compared to the gold standard (ELI...
Detailed Description
A prospective, non-blinded, non-randomized trial will be conducted at the Adult Emergency Department at the University of Maryland Medical Center and Adult Urgent Care Center, which is managed by the ...
Eligibility Criteria
Inclusion
- Adult (age \> 18 years) emergency department patients
- ED workup includes blood testing
- Confirmed history of vaccination against SARS-CoV-2
Exclusion
- Known to be pregnant at the time of evaluation
- Incarcerated at the time of evaluation
- Requires the use of an interpreter
- Patient is considered immunocompromised or has any other condition that the investigator feels makes the patient unsuitable for study inclusion.
- Has any other condition that the investigator feels makes the patient unsuitable for study inclusion
Key Trial Info
Start Date :
August 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 21 2023
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05196932
Start Date
August 31 2022
End Date
April 21 2023
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Medical Systems
Baltimore, Maryland, United States, 21201